2m 2m 2m 2m 2m 2m 2m
COMPASS THERAPTC (CMPX)
NASDAQ
$2.25-$0.01 (-0.66%)
Price as of Jul 14, 2026 5:45 AM EDT- $407.0MMarket Cap
- -22.60%1-Year Change
- BiotechnologyIndustry
COMPASS THERAPTC (CMPX)
$2.25-$0.01 (-0.66%)
CMPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.26 | ||
Change | -$0.07 (-3.00%) | ||
Open | $2.30 | ||
High | $2.31 | ||
Low | $2.19 | ||
Previous Close | $2.33 | ||
Volume | 1,879,366 | ||
30-Day Average Volume | 3,460,924 | ||
1-Week Change | -1.31% | ||
1-Month Change | 11.33% | ||
1-Year Change | -22.60% | ||
3-Year Change | -20.70% | ||
5-Year Change | -72.97% | ||
Fundamentals | |||
Shares Outstanding | 180.1M | ||
Total Assets | $205.2M | ||
Market Cap | $407.0M | ||
Enterprise Value | $351.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.3M | ||
Free Cash Flow | -$17.4M | ||
EBIT | -$18.3M | ||
EBITDA | -$18.3M | ||
Net Working Capital | $185.4M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -23 | ||
PEG | 1 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue